Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients

Head and Neck

Volumn 32, Issue 6, 2010, Pages 728-736

  Datema, Frank R ^a   Ferrier, Marciano B ^b   Van Der Schroeff, Marc P ^a   Baatenburg De Jong, Robert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Comorbidity; Cox regression; Head and neck squamous cell carcinoma; Prognostic model; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL DECISION MAKING; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HEAD AND NECK CANCER; HUMAN; KAPLAN MEIER METHOD; LARYNX CANCER; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COUNSELING; PHARYNX CANCER; PREDICTION; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGED; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LOGISTIC MODELS; MIDDLE AGED; MOUTH NEOPLASMS; OBSERVER VARIATION; PHARYNGEAL NEOPLASMS;

EID: 77952787905     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21245     Document Type: Article

References (21)

1. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996;77:834-842.
2. Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck 2001;23:718-724. (Pubitemid 32751487)
3. Piccirillo JF, Lacy PD, Basu A, Spitznagel L. Development of a new head and neck cancer-specific comorbidity Index. Arch Otolaryngol Head Neck Surg 2002;128: 1172-1179. (Pubitemid 35168108)
4. Piccirillo JF, Costas I. The impact of comorbidity on outcomes. ORL J Otorhinolaryngol Relat Spec 2004;66: 180-185.
5. Piccirillo JF, Tierney RM, Costas I, Grove L. Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-2447. (Pubitemid 38669187)
6. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005;131:27-32. (Pubitemid 40105457)
7. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-626.
8. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
10. Cleary PD, Greenfield S, Mulley AG, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 1991; 266:73-79.
11. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:1988-1996. (Pubitemid 35283461)
12. Feinstein AR. Clinical biostatistics. XIV. The purposes of prognostic stratification. Clin Pharmacol Ther 1972;13: 285-297.
13. Feinstein AR. Clinical biostatistics. XV. The purposes of prognostic stratification. I. Clin Pharmacol Ther 1972;13: 442-457.
14. Feinstein AR. Clinical biostatistics. XVI. The purposes of prognostic stratification. 2. Clin Pharmacol Ther 1972;13: 609-624.
15. Feinstein AR. Clinical biostatistics. XVII. Synchronous partition and bivariate evaluation in predictive stratification. Clin Pharmacol Ther 1972;13:755-768.
16. ACE27Comorbidity Calculator: available on-line at: http://oto.wustl.edu/ clinepi/calc.html.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
18. Harrell F. Regression modeling strategies, Springerreport New York 2001.
19. Bailey BJ. Access to health care in the United States. Arch Otolaryngol Head Neck Surg 1991;117:481-483.
20. Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003;25:1019-1026. (Pubitemid 37475264)
21. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998;20:1-7.